As earnings reports loom, Walmart emerges as a strong competitor while Target struggles with its identity. Investment expert Victoria Greene shares insights on what to expect from both retailers.
In a surprising turn, ultra-wealthy family offices are ramping up investments in biotechnology and entertainment, signaling a shift in investment strategies. Learn about the latest deals and why patience is key in biotech.
